Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.310
-0.020 (-1.50%)
Mar 9, 2026, 2:13 PM EDT - Market open
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $80.5 million as of March 9, 2026. Its market cap has decreased by -56.05% in one year.
Market Cap
80.50M
Enterprise Value
-100.21M
1-Year Change
-56.05%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $80.50M, a decrease of -89.09%. That is a compound annual growth rate of -31.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 81.73M | 9.02% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 87.27M |
| Pyxis Oncology | 85.30M |
| OKYO Pharma | 85.27M |
| Verrica Pharmaceuticals | 84.91M |
| Seres Therapeutics | 82.59M |
| Champions Oncology | 81.51M |
| aTyr Pharma | 80.79M |
| PolyPid | 79.96M |